vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and PureCycle Technologies, Inc. (PCT). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $2.7M, roughly 133.6× PureCycle Technologies, Inc.). AdvanSix Inc. runs the higher net margin — -0.8% vs -697.1%, a 696.3% gap on every dollar of revenue. AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-42.0M).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.
ASIX vs PCT — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $2.7M |
| Net Profit | $-2.8M | $-18.8M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | -2196.1% |
| Net Margin | -0.8% | -697.1% |
| Revenue YoY | 9.4% | — |
| Net Profit YoY | -892.9% | 71.0% |
| EPS (diluted) | $-0.11 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $2.7M | ||
| Q3 25 | $374.5M | $2.4M | ||
| Q2 25 | $410.0M | $1.6M | ||
| Q1 25 | $377.8M | $1.6M | ||
| Q4 24 | $329.1M | $0 | ||
| Q3 24 | $398.2M | $0 | ||
| Q2 24 | $453.5M | $0 | ||
| Q1 24 | $336.8M | $0 |
| Q4 25 | $-2.8M | $-18.8M | ||
| Q3 25 | $-2.6M | $-28.4M | ||
| Q2 25 | $31.4M | $-144.2M | ||
| Q1 25 | $23.3M | $8.8M | ||
| Q4 24 | $352.0K | $-64.7M | ||
| Q3 24 | $22.3M | $-90.6M | ||
| Q2 24 | $38.9M | $-48.2M | ||
| Q1 24 | $-17.4M | $-85.6M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | -2196.1% | ||
| Q3 25 | -0.9% | -1602.2% | ||
| Q2 25 | 7.7% | -2763.5% | ||
| Q1 25 | 7.7% | -2387.4% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | 7.5% | — | ||
| Q2 24 | 11.5% | — | ||
| Q1 24 | -7.0% | — |
| Q4 25 | -0.8% | -697.1% | ||
| Q3 25 | -0.7% | -1167.5% | ||
| Q2 25 | 7.7% | -8741.8% | ||
| Q1 25 | 6.2% | 559.0% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | -5.2% | — |
| Q4 25 | $-0.11 | $-0.14 | ||
| Q3 25 | $-0.10 | $-0.31 | ||
| Q2 25 | $1.15 | $-0.81 | ||
| Q1 25 | $0.86 | $0.05 | ||
| Q4 24 | $0.02 | $-0.40 | ||
| Q3 24 | $0.82 | $-0.54 | ||
| Q2 24 | $1.43 | $-0.29 | ||
| Q1 24 | $-0.65 | $-0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $156.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $45.9M |
| Total Assets | $1.7B | $922.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $156.7M | ||
| Q3 25 | $23.7M | $234.4M | ||
| Q2 25 | $18.4M | $284.1M | ||
| Q1 25 | $8.3M | $22.5M | ||
| Q4 24 | $19.6M | $15.7M | ||
| Q3 24 | $17.3M | $83.7M | ||
| Q2 24 | $12.1M | $10.9M | ||
| Q1 24 | $20.6M | $25.0M |
| Q4 25 | $815.2M | $45.9M | ||
| Q3 25 | $818.2M | $68.2M | ||
| Q2 25 | $823.7M | $98.9M | ||
| Q1 25 | $794.4M | $238.2M | ||
| Q4 24 | $774.6M | $180.4M | ||
| Q3 24 | $766.4M | $241.4M | ||
| Q2 24 | $746.6M | $291.6M | ||
| Q1 24 | $713.2M | $336.8M |
| Q4 25 | $1.7B | $922.7M | ||
| Q3 25 | $1.7B | $989.1M | ||
| Q2 25 | $1.6B | $1.0B | ||
| Q1 25 | $1.6B | $787.3M | ||
| Q4 24 | $1.6B | $798.4M | ||
| Q3 24 | $1.5B | $788.8M | ||
| Q2 24 | $1.5B | $719.8M | ||
| Q1 24 | $1.5B | $734.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $-28.7M |
| Free Cash FlowOCF − Capex | $36.1M | $-42.0M |
| FCF MarginFCF / Revenue | 10.0% | -1559.6% |
| Capex IntensityCapex / Revenue | 7.7% | 495.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-183.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $-28.7M | ||
| Q3 25 | $26.6M | $-38.5M | ||
| Q2 25 | $21.1M | $-36.7M | ||
| Q1 25 | $11.4M | $-38.9M | ||
| Q4 24 | $64.2M | $-31.8M | ||
| Q3 24 | $57.3M | $-33.4M | ||
| Q2 24 | $50.2M | $-40.4M | ||
| Q1 24 | $-36.2M | $-39.2M |
| Q4 25 | $36.1M | $-42.0M | ||
| Q3 25 | $66.0K | $-42.4M | ||
| Q2 25 | $-7.2M | $-45.3M | ||
| Q1 25 | $-22.6M | $-53.9M | ||
| Q4 24 | $29.8M | $-53.4M | ||
| Q3 24 | $26.8M | $-42.6M | ||
| Q2 24 | $16.7M | $-50.8M | ||
| Q1 24 | $-71.6M | $-53.5M |
| Q4 25 | 10.0% | -1559.6% | ||
| Q3 25 | 0.0% | -1743.1% | ||
| Q2 25 | -1.7% | -2747.1% | ||
| Q1 25 | -6.0% | -3409.6% | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
| Q4 25 | 7.7% | 495.1% | ||
| Q3 25 | 7.1% | 160.3% | ||
| Q2 25 | 6.9% | 521.5% | ||
| Q1 25 | 9.0% | 949.6% | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | -4.40× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
PCT
Segment breakdown not available.
